Resources
Congress Must Protect Patient Care
California hospitals are committed to caring for their patients and communities. As policymakers in Washington, D.C., consider changes to the Medicaid program (known as Medi-Cal in California) it’s critical that the impact on patient care be at the forefront of every conversation.
Issue Brief: Systemic Reimbursement Shortfalls Must Be Fixed
Medicare and Medi-Cal underfunding have put the health care system on the precipice.
Managed Care Organization Tax
On Nov. 5, California voters overwhelmingly approved Proposition (Prop) 35, making an existing tax on managed care organizations (MCO) permanent under state law — and directing most of the revenues toward expanding access to care for Medi-Cal patients through improved provider reimbursement. Now, work by the state, hospitals, and others to determine how these funds […]
Thank You To Our CHPAC 2024 Donors
Diane Abbett, California Healthcare Insurance Company, Inc. T Abraham, Hospital Council – Northern & Central California Amy Adome, MD, MPH, Sharp HealthCare Steve Aleman, Prime Healthcare Services Dimitrios Alexiou, FACHE, Hospital Association of San Diego & Imperial Counties Mark Allen, Marian Regional Medical Center Jared Amerson, Providence Saint John’s Health Center Sue Andersen, Marian Regional […]
Hospital Fee Program 9 (2024)
With each Hospital Fee Program renewal, DHCS retrieves the requisite hospital data and updates the fee and payment model as directed under the authorizing legislation found under state law (specifically, the Medi-Cal Hospital Reimbursement Improvement Act of 2013 codified at Welfare and Institutions Code sections 14169.50 through 14169.76).
Baxter Announces Expiration Dating Extensions for Certain Products Related to IV Solutions Disruption
As part of its efforts to mitigate the disruption to the supply of IV solutions after Hurricane Helene temporarily closed its North Cove, N.C., manufacturing plant, Baxter today said that it is now authorized by the Food and Drug Administration (FDA) to extend the use date of some products to provide a 24-month expiration from the manufacture date without relabeling the products. In a letter to customers today, Baxter said the extended expiration date is based on Baxter’s submission to the FDA including container closure integrity data, container functional performance data, and an analysis of product weight loss profiles for those certain product codes.
Baxter Provides Updates on Efforts to Increase Access to and Supply of IV Solutions
Register for HHS Oct. 28 webinar featuring hospital and health system leaders discussing conservation strategies
HHS, Baxter Announce Additional Mitigation Efforts to Increase Access, Supply of IV Fluids
The Department of Health and Human Services (HHS) and Baxter officials have announced additional actions to increase access and supply of IV solutions in response to the effects of Hurricane Helene on Baxter’s manufacturing facility in North Carolina. HHS’ mitigation efforts include increasing international and domestic supply chains. HHS Secretary Xavier Becerra joined other Administration leaders and officials from Baxter this afternoon for a call with stakeholders to provide updates on the IV solutions supply disruptions.
CHA Releases Resource Web Page for Nationwide IV Fluid Shortage
What’s happening: As hospitals and other health care providers nationally grapple with the shortage of IV fluids following the temporary closure of Baxter International’s manufacturing plant in Marion, N.C., CHA has compiled federal, state, and local resources to assist hospitals.
What else to know: Hurricane Helene hit the southeast in early October, causing widespread damage, including the temporary closure of Baxter’s plant — which, pre-Hurricane, manufactured 60% of the nation’s supply of IV solutions, producing 1.5 million bags per day.